Statute
BPCIA
102 published works
Biosimilars Law Blog
FDA Anticipates New Draft Biosimilar Guidances
Including biosimilars in the release of expected 2014 CDER draft guidance documents has sparked the public interest as industry, physicians, patients and others await additional cues on FDA’s implementation of…
Biosimilars Law Blog
Universities urge FDA to require certification of information exchange for biosimilar applications
A collection of associations for higher education wrote to FDA Commissioner Margaret Hamburg urging a requirement for biosimilar applicants to certify that they have complied with the information exchange and…